Back to Markets
ANAnaptysBio Inc

AnaptysBio Inc

ANABNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$55.67

-1.350000 (-2.37%)

As of 05/29/26 EDT · USD

Compare
Low: $11.40Current: $55.67High: $72.36

Key Statistics

Open

$57.06

Day High

$57.38

Day Low

$54.87

Prev. Close

$57.02

VolumeShares traded today.

491.52K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$1.62B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-63.47

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$72.36

52W LowLowest price over the past 52 weeks.

$11.40

50D MAAverage closing price over the last 50 trading days.

$53.46

200D MAAverage closing price over the last 200 trading days.

$33.15

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

-7.8%

1M

-10.7%

6M

+101.8%

YTD

+86.3%

1Y

+276.7%

About

Dostarlimab, sold under the brand name Jemperli, is a monoclonal antibody used as an anti-cancer medication for the treatment of endometrial cancer. Dostarlimab is a programmed death receptor-1 (PD-1)–blocking monoclonal antibody.

www.anaptysbio.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade ANAB

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.